Immunotheraphy despite anaphylaxis-induced myocardial infarction

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 1, 2001, Pages 89-

  Quercia, O ^a   Foschi, F G ^a   Marsigli, L ^a   Rafanelli, S ^a   Stefanini, G F ^a  

^a Ospedale di Faenza   (Italy)

Author keywords

Anaphylactic reaction; Hymenoptera venom allergy; Myocardial infarction; Systemic immunotherapy

Indexed keywords

ADULT; ANAPHYLAXIS; ANIMAL; ARTICLE; CASE REPORT; DESENSITIZATION; HEART INFARCTION; HUMAN; HYMENOPTERA; IMMEDIATE TYPE HYPERSENSITIVITY; INSECT BITE; MALE; MIDDLE AGED; CLINICAL FEATURE; DISEASE COURSE; ELECTROCARDIOGRAM; IMMUNOTHERAPY; PRIORITY JOURNAL; TREATMENT INDICATION;

ADULT; ANAPHYLAXIS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYMENOPTERA; HYPERSENSITIVITY, IMMEDIATE; INSECT BITES AND STINGS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

ADRENALIN; ANTIHISTAMINIC AGENT; HYMENOPTERA VENOM; STEROID;

EID: 0035144986     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00917.x     Document Type: Article

References (5)

1. Risk and safety of immunotherapy
2. The Hymenoptera venom study. III. Safety of venom immunotherapy
3. Fatalities from immunotherapy and skin testing
4. The value of hyposensitization therapy for bronchial asthma in children: A 14 year study
5. Position paper. Immunotherapy with Hymenoptera venoms